<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02135835</url>
  </required_header>
  <id_info>
    <org_study_id>1312-Z-SHFU-ZS-RE</org_study_id>
    <nct_id>NCT02135835</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure</brief_title>
  <official_title>A Multicentre, Parallel-Group, Randomised, Double-Blind Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Resources Sanjiu Medical &amp; Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Resources Sanjiu Medical &amp; Pharmaceutical Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of Shenfu Zhusheye in
      patients with acute heart failure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 3, 2014</start_date>
  <completion_date type="Actual">March 24, 2017</completion_date>
  <primary_completion_date type="Actual">March 24, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients whose NT - proBNP level reduce more than 30% compared to pre-treatment.</measure>
    <time_frame>0, 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decrease rate in NT-proBNP compared to pre-treatment.</measure>
    <time_frame>0, 7 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease value in NT-proBNP compared to pre-treatment.</measure>
    <time_frame>0, 7 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Likert rating scale of Dyspnoea.</measure>
    <time_frame>0, 7 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The results of Transthoracic Doppler-echocardiography .</measure>
    <time_frame>0, 7 days.</time_frame>
    <description>Left ventricular ejection fraction (LVEF) and Left Ventricular Diastolic End Diameter (LVDED) will be measured with Transthoracic Doppler-echocardiography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart function grade of NYHA.</measure>
    <time_frame>0, 7 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite endpoints.</measure>
    <time_frame>Composite endpoints will be assessed during medication period and 28 days after medication.</time_frame>
    <description>Composite endpoints were defined as death, cardiac arrest with resuscitation, readmission for heart failure, worsening heart failure with an intravenous pharmacologic agent for more than 4 hours, stroke or cases where the patient ceased active treatments because of worsening heart failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety assessments will be based on adverse event reports and the results of clinical laboratory tests, electrocardiogram.</measure>
    <time_frame>Adverse event reports will be assessed during medication period and 28 days after medication. Clinical laboratory tests will be assessed at 0, 7 days.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">365</enrollment>
  <condition>Acute Heart Failure</condition>
  <arm_group>
    <arm_group_label>Shenfu Zhusheye</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>80 ml Shenfu Zhusheye + 70 ml 5% glucose injection, ivdrip, once a day for 7 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5% glucose injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>150 ml 5% glucose injection, ivdrip, once a day for 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Shenfu Zhusheye</intervention_name>
    <arm_group_label>Shenfu Zhusheye</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5% glucose injection</intervention_name>
    <arm_group_label>Shenfu Zhusheye</arm_group_label>
    <arm_group_label>5% glucose injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Acute Heart Failure according to Guidelines for the diagnosis
             and treatment of acute heart failure 2010 of Chinese Medical Association(Participants
             whose Heart function grade of NYHA is Ⅲ～Ⅳ).

          -  LVEF≤40%.

          -  NT-pro-BNP ≥1400 pg/mL or BNP ≥ 350pg/mL.

          -  Ages 18-80, male or female.

          -  All participants signed the informed consent.

        Exclusion Criteria:

          -  Participants with abnormal liver function (ALT, AST≥3 times of upper limit of normal)
             or abnormal kidney function( Cr≥1.5 times of upper limit of normal or Cr &gt;3.0 mg/dl (&gt;
             265 µmol/L)).

          -  SBP ≥ 150mmHg.

          -  Participants with severe chronic asthmatic bronchitis or acute episode of lung
             diseases.

          -  Participants with acute coronary syndrome, cardiogenic shock, aortic dissection,
             pulmonary embolism, severe ventricular arrhythmias, complete atrioventricular block
             without cardiac pacemaker, hypertrophic obstructive cardiomyopathy, restrictive
             cardiomyopathy and severe valvular disease without surgery.

          -  Participants with advanced cancer.

          -  Breastfeeding, pregnant and potentially fertile women participant.

          -  Participants with insanity.

          -  Known allergies with Shenfu Zhusheye or its ingredients in the past.

          -  Participants who have taken part in other clinical trials in last month.

          -  Participants who abuse alcohol or other drugs in last year.

          -  Participants who are not suitable for clinical trial under doctors' consideration.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jiefu Yang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>An Hui Provincial Hospital</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fujian Provincial Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Fourth People's Hospital of Shenzhen（Futian Hospital）</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518033</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daqing peoples hospital</name>
      <address>
        <city>Daqing</city>
        <state>Heilongjiang</state>
        <zip>163000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanshi Hospital of Nanyang</name>
      <address>
        <city>Nanyang</city>
        <state>Henan</state>
        <zip>473000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450052</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xuzhou Central Hospital</name>
      <address>
        <city>Xuzhou</city>
        <state>Jiangsu</state>
        <zip>221009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jiangxi Provincial People's Hospital</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Fouth Affiliated Hospital of China Mdical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The People's Hospital of Liao Ning Province</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongren Hospital Shanghai Jiao Tong University School Of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital Of Xi'an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West China Hospital of Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital (T.C.M.) Affiliated to Sichuan Medical</name>
      <address>
        <city>Luzhou</city>
        <state>Sichuan</state>
        <zip>646000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Yibin</name>
      <address>
        <city>Yibin</city>
        <state>Sichuan</state>
        <zip>644000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of the Medical College,Shihezi University</name>
      <address>
        <city>Shihezi</city>
        <state>XIjiangweiwuerzizhiqu</state>
        <zip>832000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Xinjiang Medical University</name>
      <address>
        <city>Ürümqi</city>
        <state>Xinjiangweiwuerzizhiqu</state>
        <zip>830000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xinjiang Medical</name>
      <address>
        <city>Urumqi</city>
        <state>Xinjiang</state>
        <zip>830054</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongde hospital of Zhejiang Province</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310012</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shang Hai Chest Hospital Shanghai JiaoTong University</name>
      <address>
        <city>Shanghai</city>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2014</study_first_submitted>
  <study_first_submitted_qc>May 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2014</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

